Recent Comments

Comment RSS

Pharmacology News and Research RSS Feed - Pharmacology News and Research

Pharmacology is the study of how chemical substances interact with living systems. If substances have medicinal properties, they are considered pharmaceuticals. The field encompasses drug composition and properties, interactions, toxicology, therapy, and medical applications and antipathogenic capabilities.

FDA approves Pfizer's Geodon Capsules for the adjunctive maintenance treatment of bipolar disorder

21. November 2009 00:32
Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demonstrating that Geodon is an effective and generally well-tolerated adjunctive treatment for long-term symptom control in patients with bipolar disorder. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , , , , , , , ,

Permalink | Comments (0)

Sugar-coated polymer may offer a new solution for allergy and asthma

20. November 2009 01:36
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering conditions in a new way. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , , , ,

Permalink | Comments (0)

High blood pressure: A major risk factor for stroke and heart disease

20. November 2009 01:25
Today, Jamieson Laboratories, in partnership with the Victorian Order of Nurses (VON), is holding a one day Blood Pressure Blitz in Toronto's underground PATH system in an effort to educate consumers about the number one risk factor for stroke and a major risk factor of heart disease. [More]

Posted in: Medical Condition News

Tags: , , , , , , , , , , , , , , ,

Permalink | Comments (0)

Six new degree programs to be offered by High-Tech Institute in Minneapolis

19. November 2009 05:18
High-Tech Institute in Minneapolis will begin offering six new degree programs, with a class start set for January 11, 2010 for all programs. The school is located at 5100 Gamble Drive, Suite 200 in St. Louis Park, Minn. [More]

Posted in: Healthcare News

Tags: , , , , , , ,

Permalink | Comments (0)

Researchers develop new device with nano-sized features to grab cancer cells

19. November 2009 02:17
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. [More]

Posted in: Device / Technology News | Medical Science News | Medical Condition News

Tags: , , , , , , , , ,

Permalink | Comments (0)

Patients with recent-onset schizophrenia have raised levels of inflammatory substances

18. November 2009 11:24
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system. [More]

Posted in: Medical Research News | Medical Condition News

Tags: , , , , , , ,

Permalink | Comments (0)

Johns Hopkins University to create a Human Proteome Chip using Arrayit's technology

18. November 2009 07:41
Arrayit Corporation announced today that the new High Throughput Biology Center at Johns Hopkins University School of Medicine in Baltimore Maryland purchased Arrayit's proprietary technology to create a Human Proteome Chip to discover biomarkers for autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, autoimmune hepatitis (first identified by Dr. Zhu), lupus, and others. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , , , ,

Permalink | Comments (0)

Insights into evolving pharmacovigilance trends and their impact on biosimilars and generic products

18. November 2009 07:23
Experts from PAREXEL International Corporation, a leading global biopharmaceutical services provider, will provide insights into evolving pharmacovigilance trends and their impact on biosimilars and generic products at the World Generic Medicines Congress Americas, being held November 17 - 20, 2009 in Washington, DC. [More]

Posted in: Pharmaceutical News

Tags: , ,

Permalink | Comments (0)

ScienceWorksForUS launched by the representatives of public and private research universities

18. November 2009 01:04
Representatives of the nation's leading public and private research universities, joined by Speaker Nancy Pelosi and other Members of Congress, today announced the launch of ScienceWorksForUS, an initiative that will highlight the scientific research and related activities that have been made possible by the American Recovery and Reinvestment Act of 2009 (ARRA), also known as the stimulus. [More]

Posted in: Device / Technology News | Medical Research News

Tags: , , , , , , , ,

Permalink | Comments (0)

Alkermes commences phase 2 study of ALKS 33 in patients with alcohol dependence

17. November 2009 10:27
Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders. The study will assess the safety and efficacy of multiple doses of ALKS 33 in patients with alcohol dependence and is designed to further define the clinical profile of ALKS 33. [More]

Posted in: Drug Trial News | Medical Condition News

Tags: , , , , , ,

Permalink | Comments (0)

Perceptive Informatics announces the expansion of its medical imaging capabilities for cardiology clinical trials

17. November 2009 06:48
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has expanded its leading medical imaging capabilities with advanced nuclear imaging functionality for cardiology clinical trials. [More]

Posted in: Device / Technology News

Tags: , , , , , , , , ,

Permalink | Comments (0)

Consortium to define new modalities for treating hypertension and associated vascular complications

17. November 2009 05:25
Top Institute Pharma has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension (high blood pressure) and associated vascular complications such as heart and kidney failure, myocardial infarction and stroke. [More]

Posted in: Child Health News | Medical Condition News

Tags: , , , , ,

Permalink | Comments (0)

Researchers discover a way to boost levels of palmitoylethanolamide

17. November 2009 04:28
UC Irvine pharmacology researchers have discovered a way to boost levels of a natural body fat that helps decrease inflammation, pointing to possible new treatments for allergies, illnesses and injuries related to the immune system. [More]

Posted in: Medical Science News

Tags: , , , ,

Permalink | Comments (0)

RXi Pharmaceuticals announces financial results for the quarter ended September 30, 2009

16. November 2009 07:51
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009. [More]

Posted in: Business / Finance

Tags: , , , , ,

Permalink | Comments (0)

Fully revised and updated text on renal system

16. November 2009 05:55
Research and Markets (http://www.researchandmarkets.com/research/4fdc99/the_renal_system_a) has announced the addition of John Wiley and Sons Ltd's new report "The Renal System at a Glance, 3rd Edition" to their offering. [More]

Posted in: Medical Condition News

Tags: , , , , , , , , ,

Permalink | Comments (0)
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.